"Lipids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed)
| Descriptor ID |
D008055
|
| MeSH Number(s) |
D10
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lipids".
- Chemicals and Drugs [D]
- Lipids [D10]
Below are MeSH descriptors whose meaning is more specific than "Lipids".
This graph shows the total number of publications written about "Lipids" by people in this website by year, and whether "Lipids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 2 | 3 |
| 2005 | 1 | 4 | 5 |
| 2007 | 0 | 5 | 5 |
| 2008 | 1 | 2 | 3 |
| 2009 | 1 | 5 | 6 |
| 2010 | 1 | 2 | 3 |
| 2011 | 0 | 1 | 1 |
| 2012 | 2 | 6 | 8 |
| 2013 | 2 | 1 | 3 |
| 2014 | 0 | 2 | 2 |
| 2015 | 1 | 5 | 6 |
| 2016 | 7 | 8 | 15 |
| 2017 | 46 | 59 | 105 |
| 2018 | 59 | 74 | 133 |
| 2019 | 21 | 30 | 51 |
| 2020 | 2 | 6 | 8 |
| 2021 | 6 | 12 | 18 |
To return to the timeline, click here.
Below are the most recent publications written about "Lipids" by people in Profiles.
-
The Effects of Reduced Physical Activity on the Lipid Profile in Patients with High Cardiovascular Risk during COVID-19 Lockdown. Int J Environ Res Public Health. 2021 08 23; 18(16).
-
Blood Pressure and Lipid Profile in Hypertensive Patients Post the First COVID-19 Lockdown: "Brief Letter for Publication". High Blood Press Cardiovasc Prev. 2021 Sep; 28(5):493-494.
-
Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19. Int J Pharm. 2021 Sep 25; 607:121024.
-
Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection. Int J Pharm. 2021 Sep 25; 607:121023.
-
Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines. J Control Release. 2021 10 10; 338:201-210.
-
Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration. Commun Biol. 2021 08 11; 4(1):956.
-
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial. Wien Klin Wochenschr. 2021 Sep; 133(17-18):931-941.
-
Cholesterol 25-hydroxylase expression following immune activation in response to SARS-CoV-2 infection. Curr Opin Lipidol. 2021 08 01; 32(4):266-267.
-
Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows. Clin Chem Lab Med. 2021 11 25; 59(12):1891-1905.
-
Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis. Virol J. 2021 07 27; 18(1):157.